You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 康希諾生物-B(6185.HK)大跌超8% 成交額放大至20億港元
格隆匯 12-11 14:40
格隆匯12月11日丨康希諾生物-B(6185.HK)放量大跌8.14%,報171.6港元,成交額放大至20億港元,總市值424.6億港元。據銷售文件披露,康希諾生物股東LAV Spring以每股170港元,配售800萬股舊股,籌資13.6億港元,LAV Spring有3個月禁售期。此次配股價較186.8港元,折讓8.99%。康希諾生物上一次遭股東LAV Spring減持為今年4月。另外,墨西哥外交大臣埃塞拉德9日表示,該國衞生部已簽署一項協議,同意購買3500萬劑中國康希諾生物生產的疫苗,昨日股價曾大幅收漲11.5%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account